A Retrospective Review of the Medical Management of Hypertension and Diabetes Mellitus Following Sleeve Gastrectomy

Adam M. Tritsch, Christopher M. Bland, Christos Hatzigeorgiou, Lori B. Sweeney, Michael Phillips

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Bariatric surgery is being performed with increasing frequency in the USA as a definitive treatment for morbid obesity and associated comorbidities. Management strategies of type 2 diabetes mellitus (T2DM) and hypertension (HTN) medications in sleeve gastrectomy (SG) patients postoperatively are unclear, specifically in the immediate postoperative period and 6 months following surgery. Methods: From 01 June 2010 to 30 June 2011, at a single military medical facility, a retrospective review of 88 consecutive SG patients was conducted to examine the postoperative medical management of HTN and T2DM. Patient’s HTN and T2DM medication regimens were evaluated for 6 months postoperatively. Categorical data was analyzed using chi-square, and continuous data was compared using the Student t test. Statistical analyses were completed with Stata, version 12. Results: Fifty patients were prescribed an average of 2.21 HTN medications at baseline which was reduced to an average of 1.23 (p < 0.01) medications per patient at 1 month. Twenty-four patients received an average of 1.41 oral T2DM medications with a reduction to 0.70 (p < 0.01) on average at 1 month postoperatively. Medication changes persisted throughout the 6-month follow-up. Among T2DM patients requiring insulin therapy, the mean insulin dose was 42.1 units reduced to 16.8 units immediately postoperatively (p < 0.01) which persisted at 1 month. At 6 months, the mean insulin dose was 13.3 units. Conclusions: Medication adjustments for HTN and T2DM made immediately in the postoperative period following SG persisted throughout the 6-month follow-up period and in some patients, required further adjustments.

Original languageEnglish (US)
Pages (from-to)642-647
Number of pages6
JournalObesity Surgery
Volume25
Issue number4
DOIs
StatePublished - Apr 1 2015
Externally publishedYes

Fingerprint

Gastrectomy
Diabetes Mellitus
Type 2 Diabetes Mellitus
Hypertension
Insulin
Postoperative Period
Military Facilities
Bariatric Surgery
Morbid Obesity
Comorbidity
Students
Therapeutics

Keywords

  • Diabetes mellitus
  • Hypertension
  • Medical management
  • Obesity
  • Sleeve gastrectomy

ASJC Scopus subject areas

  • Surgery
  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics

Cite this

A Retrospective Review of the Medical Management of Hypertension and Diabetes Mellitus Following Sleeve Gastrectomy. / Tritsch, Adam M.; Bland, Christopher M.; Hatzigeorgiou, Christos; Sweeney, Lori B.; Phillips, Michael.

In: Obesity Surgery, Vol. 25, No. 4, 01.04.2015, p. 642-647.

Research output: Contribution to journalArticle

Tritsch, Adam M. ; Bland, Christopher M. ; Hatzigeorgiou, Christos ; Sweeney, Lori B. ; Phillips, Michael. / A Retrospective Review of the Medical Management of Hypertension and Diabetes Mellitus Following Sleeve Gastrectomy. In: Obesity Surgery. 2015 ; Vol. 25, No. 4. pp. 642-647.
@article{46f843fe98cf4145975529dd0b939824,
title = "A Retrospective Review of the Medical Management of Hypertension and Diabetes Mellitus Following Sleeve Gastrectomy",
abstract = "Background: Bariatric surgery is being performed with increasing frequency in the USA as a definitive treatment for morbid obesity and associated comorbidities. Management strategies of type 2 diabetes mellitus (T2DM) and hypertension (HTN) medications in sleeve gastrectomy (SG) patients postoperatively are unclear, specifically in the immediate postoperative period and 6 months following surgery. Methods: From 01 June 2010 to 30 June 2011, at a single military medical facility, a retrospective review of 88 consecutive SG patients was conducted to examine the postoperative medical management of HTN and T2DM. Patient’s HTN and T2DM medication regimens were evaluated for 6 months postoperatively. Categorical data was analyzed using chi-square, and continuous data was compared using the Student t test. Statistical analyses were completed with Stata, version 12. Results: Fifty patients were prescribed an average of 2.21 HTN medications at baseline which was reduced to an average of 1.23 (p < 0.01) medications per patient at 1 month. Twenty-four patients received an average of 1.41 oral T2DM medications with a reduction to 0.70 (p < 0.01) on average at 1 month postoperatively. Medication changes persisted throughout the 6-month follow-up. Among T2DM patients requiring insulin therapy, the mean insulin dose was 42.1 units reduced to 16.8 units immediately postoperatively (p < 0.01) which persisted at 1 month. At 6 months, the mean insulin dose was 13.3 units. Conclusions: Medication adjustments for HTN and T2DM made immediately in the postoperative period following SG persisted throughout the 6-month follow-up period and in some patients, required further adjustments.",
keywords = "Diabetes mellitus, Hypertension, Medical management, Obesity, Sleeve gastrectomy",
author = "Tritsch, {Adam M.} and Bland, {Christopher M.} and Christos Hatzigeorgiou and Sweeney, {Lori B.} and Michael Phillips",
year = "2015",
month = "4",
day = "1",
doi = "10.1007/s11695-014-1375-y",
language = "English (US)",
volume = "25",
pages = "642--647",
journal = "Obesity Surgery",
issn = "0960-8923",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - A Retrospective Review of the Medical Management of Hypertension and Diabetes Mellitus Following Sleeve Gastrectomy

AU - Tritsch, Adam M.

AU - Bland, Christopher M.

AU - Hatzigeorgiou, Christos

AU - Sweeney, Lori B.

AU - Phillips, Michael

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Background: Bariatric surgery is being performed with increasing frequency in the USA as a definitive treatment for morbid obesity and associated comorbidities. Management strategies of type 2 diabetes mellitus (T2DM) and hypertension (HTN) medications in sleeve gastrectomy (SG) patients postoperatively are unclear, specifically in the immediate postoperative period and 6 months following surgery. Methods: From 01 June 2010 to 30 June 2011, at a single military medical facility, a retrospective review of 88 consecutive SG patients was conducted to examine the postoperative medical management of HTN and T2DM. Patient’s HTN and T2DM medication regimens were evaluated for 6 months postoperatively. Categorical data was analyzed using chi-square, and continuous data was compared using the Student t test. Statistical analyses were completed with Stata, version 12. Results: Fifty patients were prescribed an average of 2.21 HTN medications at baseline which was reduced to an average of 1.23 (p < 0.01) medications per patient at 1 month. Twenty-four patients received an average of 1.41 oral T2DM medications with a reduction to 0.70 (p < 0.01) on average at 1 month postoperatively. Medication changes persisted throughout the 6-month follow-up. Among T2DM patients requiring insulin therapy, the mean insulin dose was 42.1 units reduced to 16.8 units immediately postoperatively (p < 0.01) which persisted at 1 month. At 6 months, the mean insulin dose was 13.3 units. Conclusions: Medication adjustments for HTN and T2DM made immediately in the postoperative period following SG persisted throughout the 6-month follow-up period and in some patients, required further adjustments.

AB - Background: Bariatric surgery is being performed with increasing frequency in the USA as a definitive treatment for morbid obesity and associated comorbidities. Management strategies of type 2 diabetes mellitus (T2DM) and hypertension (HTN) medications in sleeve gastrectomy (SG) patients postoperatively are unclear, specifically in the immediate postoperative period and 6 months following surgery. Methods: From 01 June 2010 to 30 June 2011, at a single military medical facility, a retrospective review of 88 consecutive SG patients was conducted to examine the postoperative medical management of HTN and T2DM. Patient’s HTN and T2DM medication regimens were evaluated for 6 months postoperatively. Categorical data was analyzed using chi-square, and continuous data was compared using the Student t test. Statistical analyses were completed with Stata, version 12. Results: Fifty patients were prescribed an average of 2.21 HTN medications at baseline which was reduced to an average of 1.23 (p < 0.01) medications per patient at 1 month. Twenty-four patients received an average of 1.41 oral T2DM medications with a reduction to 0.70 (p < 0.01) on average at 1 month postoperatively. Medication changes persisted throughout the 6-month follow-up. Among T2DM patients requiring insulin therapy, the mean insulin dose was 42.1 units reduced to 16.8 units immediately postoperatively (p < 0.01) which persisted at 1 month. At 6 months, the mean insulin dose was 13.3 units. Conclusions: Medication adjustments for HTN and T2DM made immediately in the postoperative period following SG persisted throughout the 6-month follow-up period and in some patients, required further adjustments.

KW - Diabetes mellitus

KW - Hypertension

KW - Medical management

KW - Obesity

KW - Sleeve gastrectomy

UR - http://www.scopus.com/inward/record.url?scp=84940000244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940000244&partnerID=8YFLogxK

U2 - 10.1007/s11695-014-1375-y

DO - 10.1007/s11695-014-1375-y

M3 - Article

C2 - 25656260

AN - SCOPUS:84940000244

VL - 25

SP - 642

EP - 647

JO - Obesity Surgery

JF - Obesity Surgery

SN - 0960-8923

IS - 4

ER -